Big Pharma nervously eying Apple and Google's healthcare pitches

The Financial Times has taken a look at the implications of Apple ($AAPL) and Google's ($GOOG) ever-growing interest in healthcare and life sciences. Both tech giants have made a series of plays into the fields, culminating in the release of Apple's ResearchKit. Many of the tech giants' advances have been welcomed by pharma companies and resulted in cross-industry partnerships, but the FT reports some are uneasy about the long-term implications. Article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The company's Owkin Socrates platform applies transfer and federated learning to clinical research.